Skip to content
Review

Abstract 4649: Outcomes of Percutaneous Catheter Ablation for Atrial Fibrillation in Patients with Mechanical Mitral Valve Prostheses: A Systematic Review and Meta-Analysis

Nov 2026 · Circulation · 0 citations

Abstract

Background/Purpose: Atrial fibrillation (AF) develops in 30-50% of patients with mechanical mitral valve replacement (MVR), but catheter ablation is underutilized owing to concerns about catheter entrapment and procedural safety. No systematic review has evaluated ablation in this population. We therefore assessed whether catheter ablation in mechanical MVR is safe and effective, and whether outcomes differ from non-MVR controls. Methods: Following PRISMA 2020 (PROSPERO: CRD420261324697), we searched PubMed, CENTRAL, and Embase from inception through February 8, 2026, for studies of catheter ablation for AF in adults with mechanical MVR. We assessed risk of bias with ROBINS-I (comparative studies) and the JBI Critical Appraisal Checklist (single-arm studies), and certainty with GRADE. Random-effects meta-analysis used generalized linear mixed models for proportions and inverse-variance methods for comparative outcomes. Results: Fourteen studies (489 patients; all observational) met inclusion criteria. The primary safety concern — catheter entrapment — did not occur in any of 470 patients (0/470; upper 95% CI ≤0.6% by Rule of Three; GRADE: High). Other adverse events were infrequent: tamponade 0.2% (0.0-1.0%), stroke/TIA 0.6% (0.0-2.5%), and vascular complications 3.4% (2.1-5.6%). Freedom from arrhythmia was 59.0% (95% CI: 46.9-70.1%; k=6; I 2 =79.1%; GRADE: Low), with a 95% prediction interval of 31.6-81.8%. Compared with non-MVR controls, MVR patients had non-significantly lower freedom from arrhythmia (RR=0.88; 0.74-1.05; P=0.14; k=4); this gap narrowed to RR=0.96 after excluding a study with serious confounding. MVR patients underwent repeat ablation more frequently than controls, with an absolute risk increase of 12.1% (95% CI: 3.5-23.5%; RR=1.62; 1.18-2.21; P=0.003; I 2 =0%). In a within-study analysis, pulmonary vein isolation (PVI) alone carried a 3.67-fold higher recurrence hazard than extended lesion sets (adjusted HR=3.67; 95% CI 1.32-10.25; P=0.013). Conclusions: Catheter ablation for AF in mechanical MVR is feasible, with zero entrapment and 59.0% single-procedure freedom from arrhythmia; entrapment concerns should no longer deter referral. Patients should be counseled about higher repeat ablation requirements, and extended lesion sets beyond PVI alone may improve outcomes.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.